Bright Green Corporation (BGXX)
USD 0.07
(2.15%)
USD 0.07
(2.15%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.85 Million USD | -67.67% |
| 2022 | 5.72 Million USD | 1360.58% |
| 2021 | 392.19 Thousand USD | 2.51% |
| 2020 | 382.6 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 512.69 Thousand USD | 54.78% |
| 2024 Q1 | 331.23 Thousand USD | -82.11% |
| 2023 Q3 | 1.65 Million USD | -68.34% |
| 2023 FY | 1.85 Million USD | -67.67% |
| 2023 Q4 | 1.85 Million USD | 12.23% |
| 2023 Q2 | 5.21 Million USD | 1.99% |
| 2023 Q1 | 5.11 Million USD | -10.79% |
| 2022 Q2 | 2.39 Million USD | 511.17% |
| 2022 Q1 | 392.19 Thousand USD | 0.0% |
| 2022 FY | 5.72 Million USD | 1360.58% |
| 2022 Q4 | 5.72 Million USD | 136.05% |
| 2022 Q3 | 2.42 Million USD | 1.24% |
| 2021 FY | 392.19 Thousand USD | 2.51% |
| 2021 Q2 | 393.89 Thousand USD | 0.0% |
| 2021 Q4 | 392.19 Thousand USD | 19.8% |
| 2021 Q3 | 327.36 Thousand USD | -16.89% |
| 2021 Q1 | - USD | -100.0% |
| 2020 Q4 | 382.6 Thousand USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 382.6 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Theratechnologies Inc. | 58.96 Million USD | 96.86% |
| Harrow Health, Inc. | 190.5 Million USD | 99.028% |
| Dynavax Technologies Corporation | 256.91 Million USD | 99.279% |
| Biofrontera Inc. | 5.39 Million USD | 65.701% |
| Cronos Group Inc. | 2.53 Million USD | 27.093% |
| Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -204.57% |
| Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 99.741% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | 94.902% |
| RedHill Biopharma Ltd. | 1.17 Million USD | -57.866% |
| Cumberland Pharmaceuticals Inc. | 18.42 Million USD | 89.952% |
| Radius Health, Inc. | 365.31 Million USD | 99.493% |
| Universe Pharmaceuticals INC | 5.48 Million USD | 66.223% |
| DURECT Corporation | 20.74 Million USD | 91.074% |
| ProPhase Labs, Inc. | 21.38 Million USD | 91.339% |
| Safety Shot Inc | 1.54 Million USD | -19.549% |
| Phibro Animal Health Corporation | 525.45 Million USD | 99.648% |
| China SXT Pharmaceuticals, Inc. | 2.64 Million USD | 30.054% |
| Alvotech | 1.07 Billion USD | 99.828% |
| Assertio Holdings, Inc. | 40.91 Million USD | 95.474% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | 95.541% |
| Rockwell Medical, Inc. | 13.43 Million USD | 86.221% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -181.552% |
| Procaps Group S.A. | 285.93 Million USD | 99.352% |
| Intra-Cellular Therapies, Inc. | 16.93 Million USD | 89.067% |
| SCYNEXIS, Inc. | 15.08 Million USD | 87.72% |
| Aytu BioPharma, Inc. | 15.12 Million USD | 87.76% |
| Viatris Inc. | 18.12 Billion USD | 99.99% |
| OptiNose, Inc. | 131.74 Million USD | 98.594% |
| SIGA Technologies, Inc. | 1.46 Million USD | -26.487% |
| Tilray Brands, Inc. | 387.31 Million USD | 99.522% |
| PetIQ, Inc. | 468.3 Million USD | 99.605% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -181.552% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | 99.568% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Alimera Sciences, Inc. | 67.39 Million USD | 97.253% |
| Collegium Pharmaceutical, Inc. | 674.28 Million USD | 99.725% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -70.249% |
| Organogenesis Holdings Inc. | 119.35 Million USD | 98.448% |
| Journey Medical Corporation | 17.73 Million USD | 89.556% |
| Petros Pharmaceuticals, Inc. | 8.27 Million USD | 77.626% |
| Alpha Teknova, Inc. | 30.45 Million USD | 93.92% |
| Clever Leaves Holdings Inc. | 2.08 Million USD | 11.271% |
| Lifecore Biomedical, Inc. | 130.36 Million USD | 98.579% |
| PainReform Ltd. | 86 Thousand USD | -2053.236% |
| Cosmos Health Inc. | 12.42 Million USD | 85.095% |
| Avadel Pharmaceuticals plc | 35.38 Million USD | 94.767% |
| TherapeuticsMD, Inc. | 8 Million USD | 76.867% |
| Embecta Corp. | 1.63 Billion USD | 99.887% |
| Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -2996.265% |
| Talphera, Inc. | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 586.04 Million USD | 99.684% |
| Incannex Healthcare Limited | 373 Thousand USD | -396.457% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -79.243% |
| Shineco, Inc. | 29.65 Million USD | 93.756% |
| Procaps Group, S.A. | 285.93 Million USD | 99.352% |
| ANI Pharmaceuticals, Inc. | 315.32 Million USD | 99.413% |
| Aquestive Therapeutics, Inc. | 98.82 Million USD | 98.126% |
| Lantheus Holdings, Inc. | 616.94 Million USD | 99.7% |
| Alvotech | 1.07 Billion USD | 99.828% |
| Hempacco Co., Inc. | 13.72 Million USD | 86.507% |
| Eagle Pharmaceuticals, Inc. | 62.46 Million USD | 97.036% |
| Esperion Therapeutics, Inc. | 540.94 Million USD | 99.658% |
| Kamada Ltd. | 8.74 Million USD | 78.834% |
| Indivior PLC | 281.6 Million USD | 99.342% |
| Evoke Pharma, Inc. | 5 Million USD | 62.964% |
| Flora Growth Corp. | 3.67 Million USD | 49.57% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -79.243% |
| Evolus, Inc. | 126.54 Million USD | 98.537% |
| HUTCHMED (China) Limited | 86.13 Million USD | 97.85% |
| Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 99.703% |
| Akanda Corp. | 3.99 Million USD | 53.691% |